Revenue: The sum of all revenue fields included for a company's operating activities.
Enzo Biochem, Inc. (ENZB) had Revenue of $6.40M for the most recently reported fiscal quarter, ending 2025-04-30.
| Income Statement Financials | |
|
Revenue |
$6.40M |
$-2.79M |
|
$3.92M |
|
$2.48M |
|
$9.79M |
|
$-3.39M |
|
$1.01M |
|
$-2.37M |
|
$-2.37M |
|
$-2.37M |
|
$-2.37M |
|
$-2.79M |
|
$-2.37M |
|
$-3.39M |
|
$-3.07M |
|
52.40M |
|
52.40M |
|
$-0.05 |
|
$-0.05 |
|
| Balance Sheet Financials | |
$48.28M |
|
$12.38M |
|
$15.24M |
|
$63.52M |
|
$17.01M |
|
$0.13M |
|
$3.11M |
|
$20.12M |
|
$43.40M |
|
$43.40M |
|
$43.40M |
|
52.40M |
|
| Cash Flow Statement Financials | |
$-14.24M |
|
$4.10M |
|
$-5.57M |
|
$52.37M |
|
$36.69M |
|
$-15.68M |
|
$0.52M |
|
$-5.32M |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.84 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
38.80% |
|
-52.94% |
|
-52.94% |
|
-- |
|
-37.08% |
|
-43.58% |
|
$-15.14M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.69 |
|
1.49 |
|
60.58 |
|
-5.47% |
|
-5.47% |
|
-3.74% |
|
-5.45% |
|
$0.83 |
|
$-0.29 |
|
$-0.27 |
|